Literature DB >> 2823245

Consequences of fluid loss in patients treated with ACE inhibitors.

J McMurray1, D M Matthews.   

Abstract

Three patients are described in whom haemodynamic collapse and acute renal failure occurred following intercurrent gastrointestinal fluid loss during treatment with an angiotensin converting-enzyme inhibitor. The possible consequences of blockade of the formation of angiotensin II during fluid loss are discussed.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2823245      PMCID： PMC2428483          DOI： 10.1136/pgmj.63.739.385

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  8 in total

1.  Control of glomerular filtration rate by renin-angiotensin system.

Authors:  J E Hall; A C Guyton; T E Jackson; T G Coleman; T E Lohmeier; N C Trippodo
Journal:  Am J Physiol       Date:  1977-11

2.  A need for new converting enzyme inhibitors?

Authors:  S G Ball; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

Review 3.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

Review 4.  The renin-angiotensin system in the control of systemic arterial pressure.

Authors:  A B Ribeiro; O Kohlmann; M A Saragoça; O Marson; O L Ramos
Journal:  Drugs       Date:  1985       Impact factor: 9.546

5.  Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure.

Authors:  M Packer; W H Lee; N Medina; M Yushak
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

Review 6.  The renin-angiotensin system and body function.

Authors:  I A Reid
Journal:  Arch Intern Med       Date:  1985-08

7.  Severe hypotension after first dose of enalapril in heart failure.

Authors:  J G Cleland; H J Dargie; H McAlpine; S G Ball; J J Morton; J I Robertson; I Ford
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-09

Review 8.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546
  8 in total
  5 in total

1.  Reversible impairment of renal function associated with enalapril in a diabetic patient.

Authors:  M M Albareda; R Corcoy
Journal:  CMAJ       Date:  1998-11-17       Impact factor: 8.262

2.  Serious adverse events experienced by patients with chronic heart failure taking spironolactone.

Authors:  C Berry; J J McMurray
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 3.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

4.  Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication - an observational study in general practice.

Authors:  Suzanne J Faber; Nynke D Scherpbier; Hans J G Peters; Annemarie A Uijen
Journal:  BMC Nephrol       Date:  2019-12-04       Impact factor: 2.388

5.  Effects of long-term treatment of captopril and enalapril on rat intestinal angiotensin converting enzyme specific activities.

Authors:  S Song; K W Yim; N Y Kim; B C Yoon; D H Lee; H C Jung; C Y Kim
Journal:  Korean J Intern Med       Date:  1994-07       Impact factor: 2.884
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.